{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-016686","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2023-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.790326+00:00","generated_at":"2026-06-15T02:07:20.621733+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Interpace Biosciences Q1 2023 revenue $9.8M, up 24% YoY; turns profitable","bullets":["Net revenue $9.8M (+24% YoY); test volume up ~20% to record levels.","Income from continuing ops $0.4M vs loss of $1.1M; operating income $0.7M vs loss $1.0M.","Adjusted EBITDA $1.2M vs -$0.3M; cash balance $5.6M vs $2.9M a year ago.","Added 41.9M covered lives via 8 new/updated commercial contracts in Q1.","Gross profit margin improved to 61% from 59% YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-016686","json":"https://secwatch.observer/filing/0001493152-23-016686.json","markdown":"https://secwatch.observer/filing/0001493152-23-016686.md","text":"https://secwatch.observer/filing/0001493152-23-016686.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223016686/0001493152-23-016686-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223016686/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T02:07:20.621733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5be37e6d1f835b726a608aac7f8b5b44c1b63bd2","claim":"INTERPACE BIOSCIENCES, INC. reported first quarter ended March 31, 2023 results: revenue $9.8 million.","evidence_excerpt":"today announced financial results for the first quarter ended March 31, 2023 and provided a business and financial update. First quarter Net Revenue was $9.8 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223016686/0001493152-23-016686-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$9.8 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}